Cargando…
Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma
[Image: see text] Glioblastomas (GBMs) represent the most aggressive form of brain tumor arising from the malignant transformation of astrocytes. Despite various advancements, treatment options remain limited to chemotherapy and radiotherapy followed by surgery giving an overall survival of 14–15 mo...
Autores principales: | Sharma, Sudhanshu, Kumar, Pravir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910072/ https://www.ncbi.nlm.nih.gov/pubmed/36777618 http://dx.doi.org/10.1021/acsomega.2c07904 |
Ejemplares similares
-
MDM2-C Functions as an E3 Ubiquitin Ligase
por: Kim, Jun Yeob, et al.
Publicado: (2020) -
Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2
por: García‐Cano, Jesús, et al.
Publicado: (2019) -
The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016) -
Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
por: Heyne, Kristina, et al.
Publicado: (2014) -
Tau protein binds to the P53 E3 ubiquitin ligase MDM2
por: Sola, Martina, et al.
Publicado: (2023)